Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia
Clinical trial NCT02411695 · COMPLETED
Trial details
- NCT number
- NCT02411695
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2017-01-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.